These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 28984112)
21. Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination. Toutouna L; Nikolakopoulou P; Poser SW; Masjkur J; Arps-Forker C; Troullinaki M; Grossklaus S; Bosak V; Friedrich U; Ziemssen T; Bornstein SR; Chavakis T; Androutsellis-Theotokis A Brain Res; 2016 Jul; 1642():124-130. PubMed ID: 27018293 [TBL] [Abstract][Full Text] [Related]
22. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448 [TBL] [Abstract][Full Text] [Related]
23. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017 [TBL] [Abstract][Full Text] [Related]
24. Bee Venom-Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Model of Multiple Sclerosis. Danesh-Seta T; Emami F; Nasr-Esfahani MH; Ghaedi K; Aliomrani M Neurotox Res; 2021 Aug; 39(4):1181-1188. PubMed ID: 33871814 [TBL] [Abstract][Full Text] [Related]
25. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia. Nomura T; Bando Y; You H; Tanaka T; Yoshida S Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408 [TBL] [Abstract][Full Text] [Related]
26. The cuprizone-induced changes in (1)H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine. Xuan Y; Yan G; Wu R; Huang Q; Li X; Xu H Neurochem Int; 2015 Nov; 90():185-92. PubMed ID: 26340869 [TBL] [Abstract][Full Text] [Related]
27. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease. Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510 [TBL] [Abstract][Full Text] [Related]
28. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291 [TBL] [Abstract][Full Text] [Related]
29. Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis. Yang T; Zheng Q; Zhao H; Zhang QX; Li M; Qi F; Li KN; Fang L; Wang L; Fan YP Chin J Integr Med; 2016 Dec; 22(12):932-940. PubMed ID: 26919831 [TBL] [Abstract][Full Text] [Related]
30. Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse. Sun X; Liu Y; Liu B; Xiao Z; Zhang L Exp Neurol; 2012 Oct; 237(2):304-11. PubMed ID: 22836144 [TBL] [Abstract][Full Text] [Related]
31. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Groebe A; Clarner T; Baumgartner W; Dang J; Beyer C; Kipp M Cerebellum; 2009 Sep; 8(3):163-74. PubMed ID: 19259754 [TBL] [Abstract][Full Text] [Related]
32. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum. Guglielmetti C; Praet J; Rangarajan JR; Vreys R; De Vocht N; Maes F; Verhoye M; Ponsaerts P; Van der Linden A Neuroimage; 2014 Feb; 86():99-110. PubMed ID: 23933305 [TBL] [Abstract][Full Text] [Related]
33. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis. Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519 [TBL] [Abstract][Full Text] [Related]
34. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Komoly S Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397 [TBL] [Abstract][Full Text] [Related]
35. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T; Murakami K; Bando Y; Yoshida S J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102 [TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period. Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802 [TBL] [Abstract][Full Text] [Related]
37. Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Torkildsen Ø; Brunborg LA; Thorsen F; Mørk SJ; Stangel M; Myhr KM; Bø L Exp Neurol; 2009 Jan; 215(1):160-6. PubMed ID: 19000674 [TBL] [Abstract][Full Text] [Related]
38. Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early? Palavra F; Viana SD; Henriques S; Dinis J; Martins J; Madeira MH; Santiago R; Petrella L; Sereno J; Castelo-Branco M; Pereira FC; Almeida L; Ambrósio AF; Reis F Mult Scler Relat Disord; 2022 Jul; 63():103886. PubMed ID: 35597080 [TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. Skuljec J; Gudi V; Ulrich R; Frichert K; Yildiz O; Pul R; Voss EV; Wissel K; Baumgärtner W; Stangel M J Neuropathol Exp Neurol; 2011 Sep; 70(9):758-69. PubMed ID: 21865884 [TBL] [Abstract][Full Text] [Related]
40. Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury. Renno WM; Benov L; Khan KM J Neurosurg Spine; 2017 Nov; 27(5):593-613. PubMed ID: 28777065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]